COMPASS Pathways (NASDAQ:CMPS) Receives Buy Rating from HC Wainwright

COMPASS Pathways (NASDAQ:CMPS – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a $45.00 price target on the stock. Other equities analysts have also issued research reports about the company. Royal Bank of Canada restated an “outperform” rating […]

Leave a Reply

Your email address will not be published.

Previous post American Axle & Manufacturing (NYSE:AXL) Sets New 52-Week Low Following Analyst Downgrade
Next post Abbott Laboratories (NYSE:ABT) Price Target Raised to $160.00